Antioxidant protective effects of lactitol against endotoxemia in patients with chronic viral hepatitis

Chen,Chunlei; Yu,Xiuli; Lu,Haifeng; Xiao,Dangsheng; Mao,Weiling; Li,Lanjuan

doi:10.3892/mmr.2012.1188

Antioxidant protective effects of lactitol against endotoxemia in patients with chronic viral hepatitis

Authors:
- Chunlei Chen
- Xiuli Yu
- Haifeng Lu
- Dangsheng Xiao
- Weiling Mao
- Lanjuan Li
View Affiliations

Affiliations: State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, P.R. China, The Sixth Hospital of Hangzhou, Hangzhou, P.R. China
Published online on: November 16, 2012 https://doi.org/10.3892/mmr.2012.1188
Pages: 401-405

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Although antiviral drugs are widely used in the clinic, progression to liver cirrhosis and hepatocellular carcinoma cannot yet be entirely prevented. The aim of this study was to determine the effects of lactitol in chronic viral hepatitis patients with endotoxemia. Ninety-four patients with chronic viral hepatitis were separated into two groups based on plasma endotoxin levels: one group with endotoxemia (≥45 ng/l, n=60) and one group without endotoxemia (<45 ng/l, n=34). Sixty patients with gut-derived endotoxemia were randomly and evenly divided into a lactitol treatment group and a control group. Plasma endotoxin levels in patients with chronic viral hepatitis exhibited a negative correlation with superoxide dismutase (SOD) activity (P<0.001) and a positive correlation with levels of malondialdehyde (MDA) (P<0.001). The levels of SOD in the lactitol-treated group increased (P<0.01), while the levels of MDA decreased (P<0.01). Plasma endotoxin levels decreased (P<0.01) and the number of lactobacilli and bifidobacteria in the intestinal tract increased (P<0.01 for all). These results suggest that lactitol administration is capable of reducing injury caused by oxidants through regulating intestinal flora and decreasing gut-derived endotoxemia in patients with chronic viral hepatitis.

View Figures

View References

1	Bolukbas C, Bolukbas FF, Horoz M, Aslan M, Celik H and Erel O: Increased oxidative stress associated with the severity of the liver disease in various forms of hepatitis B virus infection. BMC Infect Dis. 5:952005. View Article : Google Scholar : PubMed/NCBI
2	Muriel P: Role of free radicals in liver diseases. Hepatol Int. 3:526–536. 2009. View Article : Google Scholar
3	Demirdag K, Yilmaz S, Ozdarendeli A, Ozden M, Kalkan A and Kilic SS: Levels of plasma malondialdehyde and erythrocyte antioxidant enzyme activities in patients with chronic hepatitis B. Hepatogastroenterology. 50:766–770. 2003.PubMed/NCBI
4	Chrobot AM, Szaflarska-Szczepanik A and Drewa G: Antioxidant defense in children with chronic viral hepatitis B and C. Med Sci Monit. 6:713–718. 2000.PubMed/NCBI
5	Matiushin BN, Loginov AS, Iakimchuk GN and Tkachev VD: Activity of blood antioxidant enzymes in chronic liver damage. Vopr Med Khim. 41:54–56. 1995.(In Russian).
6	Ogetman Z, Dirlik M, Caglikulekci M, et al: The effect of aminoguanidine on blood and tissue lipid peroxidation in jaundiced rats with endotoxemia induced with LPS. J Invest Surg. 19:19–30. 2006. View Article : Google Scholar : PubMed/NCBI
7	Han DW: Intestinal endotoxemia as a pathogenetic mechanism in liver failure. World J Gastroenterol. 8:961–965. 2002.PubMed/NCBI
8	Lin RS, Lee FY, Lee SD, et al: Endotoxemia in patients with chronic liver diseases: relationship to severity of liver diseases, presence of esophageal varices, and hyperdynamic circulation. J Hepatol. 22:165–172. 1995. View Article : Google Scholar : PubMed/NCBI
9	Li L, Wu Z, Ma W, Yu Y and Chen Y: Changes in intestinal microflora in patients with chronic severe hepatitis. Chin Med J (Engl). 114:869–872. 2001.PubMed/NCBI
10	Ballongue J, Schumann C and Quignon P: Effects of lactulose and lactitol on colonic microflora and enzymatic activity. Scand J Gastroenterol Suppl. 222:41–44. 1997.PubMed/NCBI
11	Ito M, Sawada H, Ohishi K, et al: Suppressive effects of bifidobacteria on lipid peroxidation in the colonic mucosa of iron-overloaded mice. J Dairy Sci. 84:1583–1589. 2001. View Article : Google Scholar : PubMed/NCBI
12	The prevention and treatment programs of Viral hepatitis. Chin J Infect Dis. 19:56–62. 2001.
13	Wang P, Xu TY, Guan YF, Su DF, Fan GR and Miao CY: Perivascular adipose tissue-derived visfatin is a vascular smooth muscle cell growth factor: role of nicotinamide mononucleotide. Cardiovasc Res. 81:370–380. 2009. View Article : Google Scholar : PubMed/NCBI
14	Xing HC, Li LJ, Xu KJ, et al: Protective role of supplement with foreign Bifidobacterium and Lactobacillus in experimental hepatic ischemia-reperfusion injury. J Gastroenterol Hepatol. 21:647–656. 2006. View Article : Google Scholar : PubMed/NCBI
15	Wang P, Xu TY, Guan YF, et al: Nicotinamide phosphoribosyltransferase protects against ischemic stroke through SIRT1-dependent adenosine monophosphate-activated kinase pathway. Ann Neurol. 69:360–374. 2011. View Article : Google Scholar
16	Chen C, Li L, Wu Z, Chen H and Fu S: Effects of lactitol on intestinal microflora and plasma endotoxin in patients with chronic viral hepatitis. J Infect. 54:98–102. 2007. View Article : Google Scholar : PubMed/NCBI
17	Yesilova Z, Yaman H, Oktenli C, et al: Systemic markers of lipid peroxidation and antioxidants in patients with nonalcoholic fatty liver disease. Am J Gastroenterol. 100:850–855. 2005. View Article : Google Scholar : PubMed/NCBI
18	Konishi M, Iwasa M, Araki J, et al: Increased lipid peroxidation in patients with non-alcoholic fatty liver disease and chronic hepatitis C as measured by the plasma level of 8-isoprostane. J Gastroenterol Hepatol. 21:1821–1825. 2006. View Article : Google Scholar : PubMed/NCBI
19	Swietek K and Juszczyk J: Reduced glutathione concentration in erythrocytes of patients with acute and chronic viral hepatitis. J Viral Hepat. 4:139–141. 1997. View Article : Google Scholar : PubMed/NCBI
20	Irshad M, Chaudhuri PS and Joshi YK: Superoxide dismutase and total anti-oxidant levels in various forms of liver diseases. Hepatol Res. 23:178–184. 2002. View Article : Google Scholar : PubMed/NCBI
21	Finney M, Smullen J, Foster HA, Brokx S and Storey DM: Effects of low doses of lactitol on faecal microflora, pH, short chain fatty acids and gastrointestinal symptomology. Eur J Nutr. 46:307–314. 2007. View Article : Google Scholar : PubMed/NCBI
22	Kitler ME, Luginbuhl M, Lang O, Wuhl F, Wyss A and Lebek G: Lactitol and lactulose, an in vivo and in vitro comparison of their effects on the human intestinal flora. Drug Investigation. 4:73–82. 1992. View Article : Google Scholar
23	Kummel KF and Brokx S: Lactitol as a functional prebiotic. Cereal Foods World. 46:424–429. 2001.
24	Lang CH, Silvis C, Deshpande N, Nystrom G and Frost RA: Endotoxin stimulates in vivo expression of inflammatory cytokines tumor necrosis factor alpha, interleukin-1beta, -6, and high-mobility-group protein-1 in skeletal muscle. Shock. 19:538–546. 2003. View Article : Google Scholar : PubMed/NCBI
25	Caglikulekci M, Dirlik M, Pata C, et al: Effect of N-acetylcysteine on blood and tissue lipid peroxidation in lipopolysaccharide-induced obstructive jaundice. J Invest Surg. 19:175–184. 2006. View Article : Google Scholar : PubMed/NCBI
26	Shen KP, Lo YC, Yang RC, Liu HW, Chen IJ and Wu BN: Antioxidant eugenosedin-A protects against lipopolysaccharide-induced hypotension, hyperglycaemia and cytokine immunoreactivity in rats and mice. J Pharm Pharmacol. 57:117–125. 2005. View Article : Google Scholar : PubMed/NCBI
27	Wang G, Feng Y, Wang Y, Huang N, Wu Q and Wang B: Bifidobacterium cell wall proteins induced beta-defensin 2 mRNA expression in human intestinal epithelial cells. Sichuan Da Xue Xue Bao Yi Xue Ban. 34:622–624. 2003.(In Chinese).
28	Sageman WS: Reliability and precision of a new thoracic electrical bioimpedance monitor in a lower body negative pressure model. Crit Care Med. 27:1986–1990. 1999. View Article : Google Scholar : PubMed/NCBI
29	Lin MY and Chang FJ: Antioxidative effect of intestinal bacteria Bifidobacterium longum ATCC 15708 and Lactobacillus acidophilus ATCC 4356. Dig Dis Sci. 45:1617–1622. 2000. View Article : Google Scholar : PubMed/NCBI